Healthcare -
Biotechnology - NASDAQ - US
$ 1.6
1.3 %
$ 1.02 B
Market Cap
-7.43
P/E
GERN - DEPRECIATION & AMORTIZATION
Depreciation & Amortization GERN - Geron Corporation
1.22 M
LAST VALUE
18.60%
2 YEAR CAGR
9.49%
5 YEAR CAGR
38.50%
10 YEAR CAGR